1.
Jalbert JJ, Rossignol M, Astruc B, Baylé F, Nordon C, Avouac B, et al. EFFECT OF AN INSTITUTIONAL MEDICATION ADHERENCE PROGRAM FOR LONG-ACTING INJECTABLE RISPERIDONE ON ADHERENCE AND PSYCHIATRIC HOSPITALIZATIONS: EVIDENCE FROM A PROSPECTIVE COHORT STUDY. J Popl Ther Clin Pharmacol [Internet]. 2017 Jun. 9 [cited 2024 Nov. 19];24(2):e61-e70. Available from: https://mail.jptcp.com/index.php/jptcp/article/view/13